CTNM
Price
$11.94
Change
-$0.22 (-1.81%)
Updated
Jun 18 closing price
Capitalization
446.39M
58 days until earnings call
Intraday BUY SELL Signals
PROK
Price
$1.83
Change
+$0.08 (+4.57%)
Updated
Jun 18 closing price
Capitalization
375.52M
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CTNM vs PROK

CTNM vs PROK Comparison Chart in %
View a ticker or compare two or three
VS
CTNM vs. PROK commentary
Jun 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTNM is a Hold and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 22, 2026
Stock price -- (CTNM: $11.94 vs. PROK: $1.83)
Brand notoriety: CTNM and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTNM: 131% vs. PROK: 65%
Market capitalization -- CTNM: $446.39M vs. PROK: $375.52M
CTNM [@Biotechnology] is valued at $446.39M. PROK’s [@Biotechnology] market capitalization is $375.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.63B to $0. The average market capitalization across the [@Biotechnology] industry is $1.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTNM’s FA Score shows that 1 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • CTNM’s FA Score: 1 green, 4 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, CTNM is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTNM’s TA Score shows that 5 TA indicator(s) are bullish while PROK’s TA Score has 6 bullish TA indicator(s).

  • CTNM’s TA Score: 5 bullish, 5 bearish.
  • PROK’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, PROK is a better buy in the short-term than CTNM.

Price Growth

CTNM (@Biotechnology) experienced а +0.67% price change this week, while PROK (@Biotechnology) price change was +10.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.61%. For the same industry, the average monthly price growth was +8.78%, and the average quarterly price growth was +2225.89%.

Reported Earning Dates

CTNM is expected to report earnings on Aug 18, 2026.

PROK is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+2.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTNM($446M) has a higher market cap than PROK($376M). CTNM YTD gains are higher at: 4.462 vs. PROK (-18.304). CTNM has higher annual earnings (EBITDA): -66.53M vs. PROK (-149.81M). CTNM has more cash in the bank: 246M vs. PROK (225M). PROK has less debt than CTNM: PROK (3.78M) vs CTNM (6.95M). PROK has higher revenues than CTNM: PROK (889K) vs CTNM (0).
CTNMPROKCTNM / PROK
Capitalization446M376M119%
EBITDA-66.53M-149.81M44%
Gain YTD4.462-18.304-24%
P/E Ratio26.40N/A-
Revenue0889K-
Total Cash246M225M109%
Total Debt6.95M3.78M184%
TECHNICAL ANALYSIS
Technical Analysis
CTNMPROK
RSI
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
73%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
70%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
70%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 10 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 6 days ago
74%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
CTNM
Daily Signal:
Gain/Loss:
PROK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIOVX18.420.41
+2.28%
Nuveen International Opps W
GGOTX15.030.13
+0.87%
Goldman Sachs Mid Cap Growth Inv
FHLSX11.790.08
+0.68%
Fidelity Health Savings
NIEAX18.600.12
+0.65%
BNY Mellon International Equity A
FINVX16.820.07
+0.42%
Fidelity Series International Value

CTNM and

Correlation & Price change

A.I.dvisor tells us that CTNM and PMN have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTNM and PMN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
-1.81%
PMN - CTNM
28%
Poorly correlated
+1.54%
MREO - CTNM
27%
Poorly correlated
-0.19%
ZBIO - CTNM
26%
Poorly correlated
+6.46%
PROK - CTNM
26%
Poorly correlated
+4.57%
XNCR - CTNM
26%
Poorly correlated
-1.10%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RLYB. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+4.57%
RLYB - PROK
41%
Loosely correlated
+0.31%
SANA - PROK
39%
Loosely correlated
+3.62%
NRIX - PROK
39%
Loosely correlated
+2.51%
APGE - PROK
38%
Loosely correlated
+2.21%
MAZE - PROK
38%
Loosely correlated
+3.38%
More